1. Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA, editors. SEER cancer statistics review, 1975–2014. Bethesda, MD: National Cancer Institute.
https://seer.cancer.gov/csr/1975_2014/
, based on November 2016 SEER data submission, posted to the SEER web site, April 2017.
2. Ortman JM, Velkoff VA, Hogan H. An aging nation: the older population in the United States, current population reports. Washington, DC: U.S. Census Bureau; 2014. p. 25–1140.
3. Wefel JS, et al. Neurocognitive function varies by IDH1 genetic mutation status in patients with malignant glioma prior to surgical resection. Neuro-Oncology. 2016;18(12):1656–63.
4. Kesler SR, et al. The effect of IDH1 mutation on the structural connectome in malignant astrocytoma. J Neuro-Oncol. 2017;131:565–74.
https://doi.org/10.1007/s11060-016-2328-1
.
5. Wefel JS, et al. ‘Chemobrain’ in breast carcinoma? A prologue. Cancer. 2004;10:466–75.